Introduction: Robotic sacrocolpopexy (RSC) has increased dramatically over the last decade. Nationally representative cost estimates of robotic surgery for apical prolapse have yet to be reported. The study determined index and follow-up costs and healthcare utilization up to ninety days after RSC.Methods: Retrospective cohort study was conducted using Truven MarketScan data from 2008 to 2012. Patients were categorized based on route of index procedure and performance of concomitant hysterectomy. Cohorts included RSC (N=2,006), laparoscopic sacrocolpopexy (LSC) (N=10,708), abdominal sacrocolpopexy (ASC) (N=6,126), and vaginal colpopexy (VC) (N=45,808). Index and follow-up costs were calculated using inpatient, outpatient, emergency, and pharmacy services data. Healthcare utilization was determined from readmissions, emergency room visits, and outpatient visits. T-test and z-test were utilized for statistical analyses.